Topical Finasteride Dose: The Complete Guide

Commissions we earn from partner links on this page do not affect our opinions or evaluations.

Continuing our new approach, here is our complete guide to topical finasteride dosing.

Top 3 Recommended Topical Finasteride Brands

#1 Ulo (Editor’s Choice)

#2 Hims

#3 Keeps

In this article, we’ll discuss the available clinical literature and how varying doses may impact:

• Hair growth potential
• Systemic leakage
• Side effect risks

Until there is a major breakthrough in hair loss treatments, finasteride remains to be one of the best-supported interventions for hair growth, thus reinforcing the need for dosing considerations of finasteride when exploring side effect risks.

Finasteride & Hair Growth

Since earning FDA approval in 1997, finasteride has become one of the most widely used medications for treating androgenic alopecia (AGA)¹. Traditionally taken orally, finasteride works by reducing dihydrotestosterone (DHT), a hormone implicated in the miniaturization of hair follicles. While effective, oral finasteride has gained notoriety for its potential side effects, particularly in the realm of sexual health. This has prompted the rise of topical formulations as an alternative designed to minimize systemic exposure and localize DHT reduction to the scalp. But does topical finasteride live up to this promise, and more importantly, what’s the ideal dose?

This article explores topical versus oral finasteride, examines why even topicals can become systemic, and discusses the nuances of finding the “best” dose to maximize regrowth while minimizing unwanted effects.

Understanding Finasteride: Mechanism of Action

Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT). DHT is implicated in the pathogenesis of hair loss. By reducing DHT levels, finasteride slows or stops the miniaturization of hair follicles.

Orally administered finasteride has been shown to reduce serum DHT levels by over 60%, providing significant benefits in studies for 80-90% of men with AGA². However, systemic DHT reduction can also affect tissues outside the scalp, such as the reproductive organs, brain, and eyes, leading to side effects like reduced libido or sexual dysfunction in a small percentage of users³.

Topical finasteride aims to localize the DHT-reducing effects to the scalp, minimizing systemic absorption and ideally side effects. Clinical research also shows that it can work nearly as well as oral formulations in the scalp target area⁴. 

Based on our read of the current clinical research, there seem to be two main dosing categories  of topical finasteride:

• Low-dose finasteride
• High dose-finasteride

Ulo offers both of these options, allowing for flexibility of choice.

While the topical application of finasteride limits systemic absorption to some extent, it’s a misconception that it keeps the drug entirely confined to the scalp; some systemic absorption still occurs. This is because finasteride exhibits a dose-dependent response curve, meaning that while 0.01 mg of finasteride may barely reduce DHT, 0.1 mg reduces it almost as much as 5 mg (as shown below).

Finasteride Dosage (mg)	Serum DHT Reduction (%)
0.01	5%
0.05	50%
0.2	69%
1	71%
5	72%

Table 1. Efficacy of oral finasteride dose on serum DHT reduction.

As the dose increases, up to ~5 mg, hair regrowth also improves in a directional manner.

Therefore, it is possible that the same relationship may exist across varying doses of topical finasteride. So, where is the perfect balance between its effects on hair growth versus safety?

One study found that 1% topical finasteride is equivalent to 1 mg oral finasteride tablets⁶. While this is beneficial for hair regrowth, that concentration of finasteride (e.g., 10 mg per mL) will almost undoubtedly reduce serum DHT levels on par with its oral formulation.

Lower concentrations have also been used; 0.25% topical finasteride showed a reduction of ~35% in serum DHT levels, compared to ~55% for the oral treatment, with similar outcomes observed in hair regrowth (Figures 1 and 3). 

A 2022 Italian study investigated a 0.25% topical finasteride spray, with daily doses estimated up to 0.9 mg⁴. In this study, users experienced DHT reductions of ~35% in serum DHT levels, compared to ~55% for the oral treatment. However, there was a notable difference: the amount of finasteride circulating in the blood was just 1/100th to 1/200th of that found in the oral finasteride group. 

Yet another study went even lower: 0.005% applied twice daily to participants resulted in far lower serum DHT levels, indicating little to no systemic absorption, yet with good hair growth outcomes⁷.

Which Factors Determine Systemic Leakage Of Topical Finasteride?

Systemic effects depend on more than just the concentration of finasteride. It is also a function of how often the drug is used. For example, one study found that applying 1 mL of 0.25% topical finasteride twice daily reduced serum DHT by ~70%, whereas applying it once daily reduced it by only 20%⁸. 

Other variables can include:

• Drug formulation: Carrier agents can regulate the rate at which finasteride enters the bloodstream.
• Amount applied: The volume applied to the scalp can greatly affect the level of exposure.
• Days of application: It may take several days of consistent application for serum DHT levels to reach their lowest “steady-state” reduction. This is because the drug accumulates gradually in the skin and then “leaks” into the bloodstream over time⁹.

Monitoring blood DHT levels is a reliable way to gauge how much topical finasteride is entering the bloodstream from the scalp, as any reduction in blood DHT suggests the drug is circulating throughout the body and potentially affecting other organs, such as the eyes, brain, or testes.

Since systemic DHT reduction is linked to unwanted side effects, stable blood DHT levels indicate minimal off-target exposure. For those aiming to minimize systemic effects while addressing hair loss, using a low-dose topical finasteride may be preferable, especially for individuals who have experienced side effects from higher doses or oral formulations. 

If this approach suits your needs, you might consider preparing a low-dose topical solution yourself, either by crushing finasteride tablets and dissolving them in a solvent or by diluting an existing topical product. However, keep in mind that accurately measuring and maintaining the correct dose, as well as ensuring the solution’s stability, can be challenging with homemade preparations.

How Do I Choose A Dose?

Based on what we have spoken about, let’s summarize how you can think about the trade-offs.

Goal	Potential Dose	Pros	Cons
Minimize side effects	0.005-0.01% x 1-2mL	Less systemic absorption, likely lower risk of side effects	May offer slower or reduced regrowth; may still go systemic
Maximize regrowth	0.1-0.3% x 0.5-2mL	Better hair density outcomes	Blood DHT suppression likely; possible side effects
Middle-ground approach	~0.05-0.1% x 0.5-2mL	Some regrowth, some safety	Blood DHT suppression & possible side effects

If you’re especially sensitive to side effects, starting low and titrating up based on blood DHT levels or symptom response is a reasonable strategy. Tools like finasteride dilution calculators and DHT blood tests can help you to experiment safely.

Optimizing Results While Minimizing Risks

Achieving optimal hair regrowth with finasteride while minimizing unwanted side effects is entirely possible, but it requires a thoughtful and personalized approach. Because each person’s body responds differently, the most important step is to begin with testing.

Ulo provides topical products that are both designed to minimize risk and provide better results, if you’re comfortable with a small amount of systemic absorption at higher concentrations.

Start with DHT blood testing

As mentioned above, it’s essential to limit the amount of topical finasteride that ends up in your bloodstream. Rather than relying solely on estimates from clinical studies, collecting your own data through lab work is a more reliable path forward. 

Begin by testing your serum DHT levels before starting finasteride to establish a baseline. After about a month of consistent use, retest. This timeline allows the medication sufficient time to reach stable levels in the scalp and bloodstream, enabling you to assess whether the topical is having systemic effects. Blood testing is relatively simple and well worth the cost for the insight it provides.

If your second DHT reading is noticeably lower than the first, this likely means some of the drug is entering your bloodstream. Depending on the degree of change, you may want to adjust the strength or frequency of application. 

Account for Natural DHT fluctuations

DHT levels naturally fluctuate throughout the day and with the seasons, with changes observed within a range of 6-12%11. Anything beyond ~20% may point to systemic absorption of finasteride.

Due to these fluctuations, consistency in testing is important. If you do have blood testing, try to have it done at the same time of day, ideally in the morning. Other factors you can keep consistent include diet, sleep patterns, and overall lifestyle. Introducing a new variable can skew results and complicate interpretation.

Watch out for Certain Supplements

It’s not just finasteride that influences your DHT levels; other factors, including common supplements, may also play a role. Combining these may alter the efficacy of your finasteride treatment.

One study in rats found that quercetin blocked finasteride’s ability to lower DHT12. While this hasn’t been confirmed in humans, the doses used in the study were similar to those found in standard quercetin supplements. So, it may be wise to avoid taking quercetin while using finasteride.

Meanwhile, a well-cited human study found creatine supplementation increased serum DHT by 56% after 7 days of loading and 40% after 14 days of maintenance, without affecting testosterone¹³. However, a more recent 12-week RCT found no significant difference in DHT or hair health between creatine and placebo groups¹⁴. Regardless, if your goal is to maximize hair preservation, avoiding creatine may help keep your DHT levels stable.

Be Realistic and Track Your Progress

Finasteride remains one of the most effective treatments for male pattern baldness. But its full effects take time. In clinical studies, most men don’t see visible regrowth until 10-12 months in, with the most dramatic improvements typically happening during the second year of use. If you don’t notice a significant change early on, just remember that it’s a long-term commitment.

To measure your results accurately, it’s important to track your progress. Even if you don’t have access to professional imaging tools, using your smartphone to take consistent, well-lit photos in the same conditions each month can help you identify changes. Comparing these results over time is one of the easiest ways to gauge results.

Conclusion

Topical finasteride offers a promising alternative to oral treatment for androgenic alopecia, especially for those looking to reduce the risk of systemic side effects. However, it’s important to remember that topical doesn’t always mean isolated. The dose, formulation, and frequency of application all influence how much of the drug enters the bloodstream. By starting conservatively, monitoring DHT levels, and making informed adjustments, it’s possible to strike the right balance, maximizing hair regrowth while minimizing risks. With patience, consistency, and the right approach, topical finasteride can be a powerful tool in your hair restoration journey.

References

1. ^{Zito PM, Bistas KG, Patel P, et al. Finasteride. In: StatPearls. StatPearls Publishing; 2025. Accessed June 30, 2025. http://www.ncbi.nlm.nih.gov/books/NBK513329/}
2. ^{Drake L, Unger WP. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1999;41:550-554.}
3. ^{Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011;8(6):1747-1753. doi:10.1111/j.1743-6109.2011.02255.x}
4. ^{Piraccini BM, Blume‐Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Acad Dermatol Venereol. 2022;36(2):286-294. doi:10.1111/jdv.17738}
5. ^{Roberts JL, Fiedler V, Imperato-McGinley J, et al. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999;41(4):555-563.}
6. ^{Hajheydari Z, Akbari J, Saeedi M, et al. Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2009;75(1):47. doi:10.4103/0378-6323.45220}
7. ^{Mazzarella G, Loconsole G, Cammisa G, et al. Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course. Journal of Dermatological Treatment. 1997;8(3):189-192. doi:10.3109/09546639709160517}
8. ^{Caserini M, Radicioni M, Leuratti C, et al. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. International Journal of Clinical Pharmacology and Therapeutics. 2014;52:842-849. doi:10.5414/CP202119.}
9. ^{Farah HA, Brown MB, McAuley WJ. Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers. Pharm Res. 2020;37(6):112. doi:10.1007/s11095-020-02822-y}
10. ^{Rao Y, Zheng F, Zhang X, et al. In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers. AAPS PharmSciTech. 2008;9(3):860-865. doi:10.1208/s12249-008-9124-y}
11. ^{Brambilla DJ, Matsumoto AM, Araujo AB, et al. The Effect of Diurnal Variation on Clinical Measurement of Serum Testosterone and Other Sex Hormone Levels in Men. J Clin Endocrinol Metab. 2009;94(3):907-913. doi:10.1210/jc.2008-1902}
12. ^{Kaplan SA. Reduction of Rat Prostate Weight by Combined Quercetin-Finasteride Treatment is Associated With Cell Cycle Deregulation. The Journal of Urology. Published online March 2005. doi:10.1016/S0022-5347(05)60390-4}
13. ^{van der Merwe J, Brooks NE, Myburgh KH. Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clin J Sport Med. 2009;19(5):399-404. doi:10.1097/JSM.0b013e3181b8b52f}
14. ^{Lak M, Forbes SC, Ashtary-Larky D, et al. Does creatine cause hair loss? A 12-week randomized controlled trial. J Int Soc Sports Nutr. 2025;22(sup1):2495229. doi:10.1080/15502783.2025.2495229}